Corcept director granted 12,500 stock options
Corcept Therapeutics director James N. Wilson received a grant of 12,500 stock options on May 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corcept Therapeutics director James N. Wilson received a grant of 12,500 stock options on May 21, 2026. Each option allows him to buy Common Stock at an exercise price of $59.69 per share, expiring on May 21, 2036.
The options cover 12,500 underlying shares and were awarded as compensation, not purchased in the open market. They become exercisable in equal monthly installments over one year starting on May 21, 2026, contingent on his continued service on each monthly vesting date.
Insider Trade Summary
Grant/Award: 12,500 shares
Grant/Award
1 txn
Insider
WILSON JAMES N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 12,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.
Key Figures
Options granted: 12,500 options
Exercise price: $59.69 per share
Underlying shares: 12,500 shares
+3 more
6 metrics
Options granted
12,500 options
Stock Option grant to director on May 21, 2026
Exercise price
$59.69 per share
Exercise price of stock options
Underlying shares
12,500 shares
Common Stock underlying the options
Expiration date
May 21, 2036
Option expiration
Vesting period
1 year
Monthly vesting from May 21, 2026 over one year
Post-transaction options
12,500 options
Total derivative holdings following transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, Common Stock, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 59.6900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-21T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vesting financial
"Exercisable ratably in equal installments on each monthly anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Corcept Therapeutics (CORT) director James N. Wilson report on this Form 4?
He reported receiving a grant of 12,500 stock options for Corcept Therapeutics Common Stock. These options were awarded as compensation, not bought in the market, and give him the right to purchase shares at a fixed exercise price of $59.69 per share.
What are the key terms of the 12,500 Corcept (CORT) stock options granted to James N. Wilson?
The grant covers 12,500 stock options with an exercise price of $59.69 per share and an expiration date of May 21, 2036. The options relate to 12,500 underlying shares of Common Stock and were reported as a grant or award acquisition.
How do the Corcept (CORT) stock options granted to James N. Wilson vest?
The options vest ratably in equal installments on each monthly anniversary of May 21, 2026, over a one-year period. Vesting is conditioned on his continued service as of each monthly vesting date, meaning unvested portions depend on ongoing board service.
What is James N. Wilson’s reported option position in Corcept (CORT) after this grant?
After the reported transaction, he holds 12,500 stock options related to Corcept Common Stock. This amount matches the size of the grant, indicating the newly awarded options constitute his reported derivative position in this filing, with no additional option holdings listed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
